Welcome to LookChem.com Sign In|Join Free

CAS

  • or

59786-31-1

Post Buying Request

59786-31-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

59786-31-1 Usage

General Description

3-Bromoisonicotinic acid methyl ester is a chemical compound with the molecular formula C7H6BrNO2. It is a derivative of isonicotinic acid and is commonly used as a building block in organic synthesis, particularly in the production of pharmaceuticals and agrochemicals. 3-BROMOISONICOTINIC ACID METHYL ESTER is known for its potential use as an anti-inflammatory and anti-cancer agent, and it has also shown activity against certain bacterial and fungal strains. Its methyl ester form makes it a versatile reagent for various chemical reactions, and its bromine substituent confers unique properties that are useful for creating new compounds with specific biological activities. Overall, 3-Bromoisonicotinic acid methyl ester is a valuable compound in the field of medicinal and agricultural chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 59786-31-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,7,8 and 6 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 59786-31:
(7*5)+(6*9)+(5*7)+(4*8)+(3*6)+(2*3)+(1*1)=181
181 % 10 = 1
So 59786-31-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H6BrNO2/c1-11-7(10)5-2-3-9-4-6(5)8/h2-4H,1H3

59786-31-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 3-bromoisonicotinate

1.2 Other means of identification

Product number -
Other names methyl 3-bromopyridine-4-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:59786-31-1 SDS

59786-31-1Relevant articles and documents

HEPATITIS B CORE PROTEIN MODULATORS

-

Page/Page column 83, (2018/04/13)

The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound of formula:

Palladium NNC Pincer Complex as an Efficient Catalyst for the Cycloisomerization of Alkynoic Acids

Conde, Nerea,SanMartin, Raul,Herrero, María Teresa,Domínguez, Esther

supporting information, p. 3283 - 3292 (2016/10/21)

A two-step (nucleophilic substitution/palladation by oxidative addition) sequence provides a high-yielding access to a non-symmetrical palladium NNC pincer complex. A number of terminal and internal alkynoic acids with different substitution patterns at the α- and β-positions are regio- and diastereoselectively cycloisomerized to the corresponding exocyclic enol lactones in the presence of exceedingly low amounts of the latter palladium complex, so that unprecedented turnover numbers and frequencies ranging from 1,000,000 to 700,000 and from 41,667 to 9722 h?1, respectively, are achieved. The optimized protocol, based on the use of a catalytic amount of triethylamine as base, allows an easy real-time monitoring of the reaction by NMR spectroscopy. Several pieces of evidence in favor of the direct participation of the above pincer complex as the catalyst of the reaction have been gathered from kinetic and poisoning experiments. (Figure presented.).

1-(2-PHENOXYMETHYLHETEROARYL)PIPERIDINE AND PIPERAZINE COMPOUNDS

-

Page/Page column 23-24, (2011/10/10)

The invention relates to compounds of formula I: where X, HAr, a, and R1 through R6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin and norepinephrine reuptake inhibitors. The invention also relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 59786-31-1